- Home
- LOGI vs NBIX Comparison
LOGI vs NBIX Comparison
Compare LOGI & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOGI
- NBIX
- Stock Information
- Founded
- LOGI 1981
- NBIX 1992
- Country
- LOGI Switzerland
- NBIX United States
- Employees
- LOGI N/A
- NBIX 1800
- Industry
- LOGI Computer peripheral equipment
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LOGI Technology
- NBIX Health Care
- Exchange
- LOGI Nasdaq
- NBIX Nasdaq
- Market Cap
- LOGI 12.9B
- NBIX 12.4B
- IPO Year
- LOGI 1997
- NBIX 1996
- Fundamental
- Price
- LOGI $92.69
- NBIX $129.11
- Analyst Decision
- LOGI Buy
- NBIX Strong Buy
- Analyst Count
- LOGI 8
- NBIX 20
- Target Price
- LOGI $85.71
- NBIX $163.20
- AVG Volume (30 Days)
- LOGI 483.0K
- NBIX 831.5K
- Earning Date
- LOGI 07-21-2025
- NBIX 07-31-2025
- Dividend Yield
- LOGI 1.81%
- NBIX N/A
- EPS Growth
- LOGI 6.72
- NBIX N/A
- EPS
- LOGI 4.13
- NBIX 2.96
- Revenue
- LOGI $4,554,900,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- LOGI $4.66
- NBIX $16.29
- Revenue Next Year
- LOGI $5.43
- NBIX $15.08
- P/E Ratio
- LOGI $21.64
- NBIX $43.66
- Revenue Growth
- LOGI 5.97
- NBIX 21.73
- 52 Week Low
- LOGI $64.73
- NBIX $84.23
- 52 Week High
- LOGI $105.65
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- LOGI 68.89
- NBIX 64.45
- Support Level
- LOGI $87.60
- NBIX $125.02
- Resistance Level
- LOGI $90.63
- NBIX $128.66
- Average True Range (ATR)
- LOGI 1.34
- NBIX 2.80
- MACD
- LOGI 0.56
- NBIX -0.12
- Stochastic Oscillator
- LOGI 95.98
- NBIX 77.34
About LOGI Logitech International S.A.
Logitech was founded in 1981 and is headquartered in Lausanne, Switzerland. The company specializes in designing and manufacturing computer peripherals such as mice, keyboards, webcams, conference room cameras, headsets, and music-related products like wireless speakers.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.